Logotipo do repositório
 

Publicação:
Central alpha-adrenergic agonists and need-induced 3% NaCl and water intake

dc.contributor.authorYada, M. M.
dc.contributor.authorPaula, Patricia Maria de [UNESP]
dc.contributor.authorMenani, José Vanderlei [UNESP]
dc.contributor.authordeLuca, L. A.
dc.contributor.institutionUniversidade Estadual Paulista (Unesp)
dc.date.accessioned2014-05-20T15:26:38Z
dc.date.available2014-05-20T15:26:38Z
dc.date.issued1997-05-01
dc.description.abstractIn the present study, noradrenaline (NOR, alpha-non-specific adrenergic agonist), clonidine (CLO, alpha(2)), phenylephrine (PHE, alpha(1)) or isoproterenol (ISO, beta-agonist) was injected in the medial septal area (MSA) of water-deprived, sodium-deplete or food-deprived rats. NOR (80, 160 nmol) inhibited the intake of 3% NaCl, water deprivation-induced and meal-associated water intake. Food deprivation-induced food intake and 10% sucrose intake were not altered by NOR. CLO (10, 20, 30, 40 nmol) inhibited (80-100% inhibition compared to control during 60 min) the intake of 3% NaCl, water deprivation-induced and meal-associated water intake. CLO had a weaker inhibition on food and 10% sucrose intake (30-50% less than the control during 60 and 15 min, respectively). PHE (160 nmol) inhibited 3% NaCl intake and 10% sucrose intake (30% less than the control for 15-30 min). ISO (160 nmol) did not after water or 3% NaCl intake. NOR induced an increase, CLO and ISO induced a decrease, and PHE no alteration in mean arterial pressure. NOR did not alter water or 3% NaCl intake when injected unilaterally into the caudate nucleus. The results suggest that NOR injected in the MSA acts on alpha(2)-adrenergic receptors inducing a specific inhibition of 3% NaCl and water intake. (C) 1997 Elsevier B.V.en
dc.description.affiliationPAULISTA STATE UNIV UNESP,DEPT PHYSIOL SCI,SCH DENT,BR-14801903 SAO PAULO,BRAZIL
dc.description.affiliationUnespPAULISTA STATE UNIV UNESP,DEPT PHYSIOL SCI,SCH DENT,BR-14801903 SAO PAULO,BRAZIL
dc.format.extent137-143
dc.identifierhttp://dx.doi.org/10.1016/S0091-3057(96)00317-6
dc.identifier.citationPharmacology Biochemistry and Behavior. Oxford: Pergamon-Elsevier B.V., v. 57, n. 1-2, p. 137-143, 1997.
dc.identifier.doi10.1016/S0091-3057(96)00317-6
dc.identifier.issn0091-3057
dc.identifier.lattes0201361251312074
dc.identifier.lattes1023597870118105
dc.identifier.orcid0000-0001-5433-4493
dc.identifier.urihttp://hdl.handle.net/11449/36776
dc.identifier.wosWOS:A1997XA08800019
dc.language.isoeng
dc.publisherElsevier B.V.
dc.relation.ispartofPharmacology Biochemistry and Behavior
dc.relation.ispartofjcr2.538
dc.relation.ispartofsjr1,150
dc.rights.accessRightsAcesso restritopt
dc.sourceWeb of Science
dc.subjectnoradrenalinept
dc.subjectclonidinept
dc.subjectphenylephrinept
dc.subjectisoproterenolpt
dc.subjectadrenergic agonistspt
dc.subjectmedial septal areapt
dc.subjectwater intakept
dc.subjectsalt intakept
dc.subjectfood intakept
dc.subjectblood pressurept
dc.titleCentral alpha-adrenergic agonists and need-induced 3% NaCl and water intakeen
dc.typeArtigopt
dcterms.licensehttp://www.elsevier.com/about/open-access/open-access-policies/article-posting-policy
dcterms.rightsHolderElsevier B.V.
dspace.entity.typePublication
relation.isDepartmentOfPublicationb3ba3d9c-022e-4521-8805-0bcceea7372e
relation.isDepartmentOfPublication.latestForDiscoveryb3ba3d9c-022e-4521-8805-0bcceea7372e
relation.isOrgUnitOfPublicationca4c0298-cd82-48ee-a9c8-c97704bac2b0
relation.isOrgUnitOfPublication.latestForDiscoveryca4c0298-cd82-48ee-a9c8-c97704bac2b0
unesp.author.lattes0201361251312074[2]
unesp.author.lattes1023597870118105
unesp.author.orcid0000-0001-5433-4493[2]
unesp.author.orcid0000-0003-1167-4441[3]
unesp.campusUniversidade Estadual Paulista (UNESP), Faculdade de Odontologia, Araraquarapt
unesp.departmentFisiologia e Patologia - FOARpt

Arquivos

Licença do Pacote

Agora exibindo 1 - 1 de 1
Carregando...
Imagem de Miniatura
Nome:
license.txt
Tamanho:
1.71 KB
Formato:
Item-specific license agreed upon to submission
Descrição: